CES 2022 Las Vegas: Taiwan Startup PrecisemAb: Safest Antibody Treatment, No Side Effects PrecisemAb Biotech, a biotechnology research company based in Kaohsiung, Taiwan, continues to stay true to its vision of enhancing antibody drugs by reducing side effects through the patented Universal Antibody Lock technology. Patients are provided with the safest possible therapy thanks to the conditionally activated antibody treatment, PrecisemAb will participate in person at US bio 2022. This transformational way of developing treatments will ensure that affected patients do not risk further aggravating their medical conditions. PrecisemAb copies parts of the antibody structure but not entirely to produce…